Free flap loss caused by heparin-induced thrombocytopenia and thrombosis (HITT) : a case report and literature review = Trombocitopenia eparino-indotta e trombosi (HITT): Una causa sottostimata di fallimento di lembi liberi : Case report e revisione della letteratura by E. Segna et al.
527
ACTA OTORHINOLARYNGOLOGICA ITALICA 2016;36:527-533; doi: 10.14639/0392-100X-1188
Case series and reports 
Free flap loss caused by heparin-induced 
thrombocytopenia and thrombosis (HITT):  
a case report and literature review
Trombocitopenia eparino-indotta e trombosi (HITT): una causa sottostimata  
di fallimento di lembi liberi: case report e revisione della letteratura
E. SEGNA, A.R. BOLZONI, C. BASERGA, A. BAJ
Chirurgia Maxillo-facciale e Odontostomatologia, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 
Università degli Studi di Milano, Italy
SUMMARY
Heparin-induced thrombocytopenia and thrombosis (HITT) represents a dramatic condition that is difficult to diagnose because of nu-
anced clinical presentation. Therefore, in every case of microvascular thrombosis during heparin-therapy prompt suspicion about HITT is 
necessary to avoid flap necrosis. We present a case of HITT which, as the 8 other articles reviewed, clearly shows that HITT is difficult to 
diagnose and complex to manage. Microvascular reconstruction is the first choice in head and neck reconstruction; unfortunately, dramatic 
outcomes in free flap surgery due to unpredictable thrombotic events are still reported in the English literature. More knowledge is required 
about HITT and reaching a consensus about thrombotic prevention in microsurgery could be helpful. Furthermore, a careful anamnesis can 
help minimise unexpected situations.
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RIASSUNTO
La trombocitopenia eparino-indotta con trombosi rappresenta una complicanza che può portare a esiti drammatici nella chirurgia rico-
struttiva microvascolare, tanto più che il suo riconoscimento non è sempre semplice. In ogni caso di trombosi microvascolare, in corso 
di terapia eparinica, il sospetto di HITT deve subito insorgere, così da poter intercettare e trattare la catena di eventi che porterebbe alla 
necrosi del lembo ricostruttivo. Presentiamo un caso che dimostra quanto possa essere difficile la diagnosi di HITT, così come appare negli 
altri reports reperibili in letteratura internazionale. I lembi microvascolari sono il gold standard nella chirurgia ricostruttiva cervico-fac-
ciale: purtroppo però il successo della metodica può essere inficiato da eventi trombo-embolici imprevedibili. Crediamo che una maggior 
divulgazione e la formulazione di domande anamnestiche specifiche possano essere utili nel limitare le conseguenze devastanti della HITT. 
PAROLE CHIAVE: Lembi liberi microchirurgici • Trombosi • Disordini della coagulazione • Reazioni avverse ai farmaci 
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Introduction
Microvascular tissue transfer is the first choice in the oral 
cavity reconstruction, especially in oncological resec-
tion 1. The efficacy of this technique has progressively in-
creased during years 2 3: improvements in optical technol-
ogies, surgeons’ attitudes and confidence with head and 
neck microvascular reconstruction and all its anatomical 
variations 4, in association with accurate patient selection 
have led to a global survival rate of 95-99% 5.
Despite this enormous success, there are still some unpre-
dictable causes of failure: among thrombotic events, hep-
arin-induced thrombocytopenia and thrombosis (HITT) 
represents a dramatic condition that is frequently mis-
recognised and consequently, very difficult to treat in a time-
ly manner 6-12. HITT has devastating outcomes and greater 
information and understanding are needed about the con-
dition: until now, only 8 papers have been published in the 
English literature: herein we report our experience on HITT 
through presentation of a case report.
We conducted a research on PubMed focusing on 2 key-
words “HITT/HIT + microvascular free flap reconstruction” 
and we found 6 publications and 1 systematic review re-
porting a total of 9 cases of HITT in microvascular surgery 
(Table I), confirming that HITT is not a widely documented 
condition in the medical literature. In 2008, Tremblay et 
al. 6 described 2 cases of HITT in heparin naïve patients, 
both confirmed by positive anti-heparin antibody tests. They 
both suffered from venous congestion within hours follow-
ing the intervention (respectively at 26 and 48 hours) af-
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ter having received unfractioned heparin (UFH). The first 
case was treated with leeches and anticoagulation therapy 
(argatroban) for about 1 month until he had a total free flap 
loss. In the second case, heparin was stopped promptly and 
danaparoid sodium was started, which worked adequately. 
Schleich et al. 7 reported a case of HITT in a patient treated 
with a latissimus dorsi flap with an unknown story of hep-
arin exposure. Six hours after surgery a decreased arterial 
Doppler signal, platelet count drop and positive antibody 
test confirmed a suspicion of HITT. Heparin was inter-
Table I. Literature review.
Author, 
year
Number 
of 
patients
Clinical 
manifestation 
(arterious, 
venous)
Onset time Time 
to hitt 
diagnosis
Pre-hitt 
therapy
Post-hitt 
therapy
Hitt therapy Previous 
herapin 
exposure
Confirmation 
of Hitt by 
antibody test
Tremblay, 
2008
2 Case 1: venous 
congestion
Case 2: venous 
congestion
Case 1: 26 
hours
Case 2: 48 
hours
Case 1: 12 
days
Case 2: 11 
days
Case 1: 
Heparin 5000 
U sc twice 
daily
Case 2: 
Heparin 5000 
U sc twice 
daily, ASA 80 
mg daily
Case 1: 
heparinised 
gauzes, 
Leeches, 
Heparin 
perfusion
Case 2: 
continuous 
heparin infusion, 
Heparin 6000 
U boluses, 
Leeches
Case 1: 
Heparin 
discontinued,
Argatroban
Case 2: 
Heparin 
discontinued,
Orgaran for 
17 days
Case 1: no
Case 2: 
unknown
Case 1 & 2: yes
Schleich, 
2008
1 Venous 
thrombosis, 
decreased 
doppler sign
6 hours 6 hours Systemic 
herapinisation
IV derapi 
perfusion
Heparin 
discontinued,
Argatroban 
for 5 days, 
long term 
Warfarin for 3 
months
Unknown Yes
Busch, 
2009
2 Case 1: 
malperfusion
Case 2: arterial 
thrombosis
Case 1: 12 
hours
Case 2: 
referred 
from another 
hospital
Case 1: 
unknown
Case 2: 
unknown
Case 1: 
unknown
Case 2: 
unknown
Case 1: 
unknown
Case 2: 
unknown
Case 1: 
Heparin 
discontinued,
Lepirudin
Case 2: 
Heparin 
discontinued,
Lepirudin
Case 1: 
unknown
Case 2: 
yes
Case 1 & 2: yes
McCleave, 
2010
1 Venous 
congestion and 
thrombosis, 
venous 
and arterial 
thrombosis
5 days 6 days LMWH preop, 
Heparin 
5000 U
Heparin infusion Heparin 
discontinued,
Lepirudin, 
long term 
Warfarin
No Antibody test 
negative, 
but platelet 
aggregation 
assay positive
Medina, 
2010
1, 2 flaps 1st flap: 
venous 
congestion, 
necrotic tissue
2nd flap: 
venous 
congestion
st flap: 4 days
2nd flap: 1 
day
12 days ASA, Lovenox Heparin 5000 U 
boluses 
Heparin 
discontinued,
Leeches,
Argatroban, 
long term 
Coumadin
Unknown No. HITT 
confirmed by 
hypercoaguable 
workup
Tessler, 
2013
1, 2 flaps 1st flap: 
venous 
congestion, 
decreased 
doppler sign
2nd flap: 
arterial 
thrombosis
Immediately 
compromised, 
1st flap 
failure: 2 days
2nd flap 
failure: 6 days 
6 days Heparin drips, 
leeches
tPA 6 mg 
in a close 
loop circuit, 
Enoxaparin 40 
mg sc daily
Heparin 
discontinued,
fondaparinux, 
long term 
Warfarin
Unnown Yes
Zaman, 
2014
1 Arterial 
thrombosis
6 hours Unknown Unknown Heparin 5000 U 
iv, Heparin 5000 
U twice daily
Heparin 
discontinued, 
Danaparoid 
infusion
Unknown Yes
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rupted and anticoagulation was switched to argatroban. 
Warfarin was mandatory as long term therapy. 
In 2009, Busch et al. 8 published 2 cases of HITT with a 
total flap loss with early onset, recurrent arterial throm-
bosis and no significant decrease in platelets. In the first 
case, HITT was diagnosed 12 hours post-operatively and 
was confirmed by positive antibody test in a patient with 
previous heparin exposure. Microvascular anastomoses 
were unsuccessfully revised 12 times. The second case 
reported was a flap failure due to HITT that occurred at an 
unknown period after surgery. HITT antibodies were pos-
itive and heparin was immediately stopped and changed 
into lepirudin; the defect was reconstructed with a second 
free flap 10 days after heparin suspension. 
McCleave et al. 9 published a paper in 2010 describing the 
case of a heparin naïve patient which had both an arte-
rial and a venous congested flap 5 days after surgery with 
a negative antibody test and a positive platelet aggrega-
tion assay. He was unsuccessfully treated with explora-
tion, heparin was interrupted and lepirudin was initiated. 
Warfarin was also mandatory as long-term therapy in this 
case. 
In 2010 a paper by Medina et al. 10 reported the failure of 
2 free flaps due to HITT in the same patient with unknown 
prior heparin exposure. Four days after performing the 
1st flap, a second one was done. Venous congestion was 
noted immediately in the 2nd flap, which was successfully 
treated with leeches and argatroban. HITT was diagnosed 
thanks to a hypercoagulability workup. 
Tessler et al. 11 in their review in 2013 analysed the litera-
ture by dividing papers in 3 groups: prior heparin expo-
sure, heparin naive and prior heparin status not discussed. 
In each group, the number of patients, HITT flap char-
acteristics, time until flap failure, treatment of HITT and 
confirmation of HITT by antibody test were analysed. 
They also reported a case of an ALT flap failure 2 days 
after surgery in a patient with a chronic right malleolus 
wound and no story of previous heparin exposure. Anas-
tomosis were revised twice and a therapy with tPA in the 
operating theatre and leeches afterward was used, and 
starting on the 4th day RFFF was performed and persisted 
with good perfusion for 4 days. Thrombosis manifested 
again: thrombolysis with tPA and attempt of re-anasto-
mosis were done unsuccessfully; the final decision was 
positioning a vacuum assisted closure therapy. HITT was 
diagnosed afterwards using an ELISA test and heparin 
was immediately stopped in favour of fondaparinux. De-
spite anticoagulant therapy, a trans-tibial amputation was 
needed because of deep venous thrombosis (DVT). 
Zaman et al. 12 wrote a letter to the editor in 2014 to expose 
a case of a free gracilis flap partial failure 6 hours after 
surgery due to an arterial thrombosis, so the arterial anas-
tomosis was revised. Post-operatively over the next few 
days the flap again showed signs of failure. At re-explora-
tion, both the artery and vein were thrombosed and it was 
impossible to re-establish flow. The flap was removed, the 
wound debrided and a negative pressure dressing was ap-
plied. The platelet count was trending downward prior to 
the gracilis free flap. A diagnosis of HITT was considered 
and anti-heparin antibody assays were positive. Heparin 
was ceased and the patient was started on danaparoid in-
fusion. The platelet count returned to normal limits within 
3 days following cessation of heparin. Because of platelet 
count stability, his lower limb defect was reconstructed 
with a right latissimus dorsi free muscle flap. This second 
flap had an unremarkable post-operative course. 
Case report
A 40-year-old non-smoking man, F.M., with no co-mor-
bidities presented. He reported a fracture of the right 
knee, occurring 20 years ago; we after discovered that on 
this occasion he had had anti-thrombotic prophylaxis with 
sub-cutaneous heparin. 
The patient came to our attention for squamous cell crci-
noma (SSC) of the lateral border of the tongue (cT2N0), 
diagnosed in September 2015. We performed the usual 
pre-operative assessments (blood exam, ECG, chest ra-
diograph, anaesthesiological evaluation) and no surgi-
cal contraindications were found. We performed partial 
glossectomy, selective neck dissection level I-III, and the 
defect was reconstructed with a left anterolateral thigh 
(ALT) flap. As per our routine, before cutting the de-
scending branch of the deep circumflex artery, a heparin 
bolus was administered (2500 I.U.). The arterial and the 
two venous microanastomoses were performed on the su-
perior thyroid artery and on the thyreolinguofacial trunk 
and on the superior thyroid vein, respectively. During the 
microsurgical time, the vessels were washed only with 
heparinised solution. Intra-operative angiography with 
indocyanine green was negative. The surgery was carried 
out unremarkably, and no surgical or anaesthesiological 
problems were seen. As per routine, we prescribed nad-
roparin 4000 I.U. daily. About 24 hours after surgery the 
flap appeared mildly congested, and application of med-
ical leeches was initiated. We continued with hourly flap 
monitoring, but the clinical suspicion of mild-to moderate 
congestion persisted. On the morning of the 2nd post-op-
erative day the flap colour had turned to blue, the tem-
perature was decreased and the blood color, at the punc-
ture, was quite dark: the patient was thus returned to the 
operating theatre. As expected, multiple venous thrombi 
were detected while the arterial flow was still valid. We at-
tempted to remove the thrombi with direct administration 
of fibrinolytic drugs (6 mg of tissue plasminogen activa-
tor [tPa]) and by mechanical thrombolysis with a Fogarty 
catheter. Both maneuvers were relatively ineffective: the 
artery was still working, but without venous drainage. The 
flap appeared to be irrecoverable, so we removed the ALT 
flap and reconstructed the tongue defect with a left radial 
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forearm free flap (RFFF): the microvascular anastomo-
ses were performed again on the superior thyroid artery 
and the internal jugular vein, in a termino-lateral fashion. 
Vessel patency was tested with indocyanine green. The 
RFFF showed a good perfusion for about 24 hours; un-
fortunately, impairment of the venous drainage was noted 
on post-operative day 3. The patient was returned to the 
operating theatre again. At surgical exploration, we dis-
covered the left internal jugular vein completely occluded 
by thrombi. We tried once again to remove the thrombi, 
but they continued to reform intraoperatively and it was 
not possible to re-establish venous flow. The flap ap-
peared still alive and so we performed a second venous 
anastomosis on the superior thyroid vein (Fig. 1). At the 
end of this third surgery, the flap perfusion was good and 
continuous heparin infusion had been started to contrast 
thrombophilia. During these 72  hours, blood exam, co-
agulation test and platelet counts did not show significant 
alterations (Fig.  2), and the patient’s general conditions 
were good. After about 24 hours of intravenous heparin 
(3000 I.U./day), haematomas formed in each surgical site 
(left thigh, left forearm, left neck): we evacuated the cer-
vical and the antebrachial haematomas in the operating 
room. The flap perfusion continued well, the forearm skin 
was pink and no stasis was detected (Fig. 3). The situation 
worsened on the 5th post-operative day: the RFFF started 
to suffer, it became blue (Fig. 4) and, in addition to the lo-
cal problem, systemic manifestations showed: venous ac-
cesses, both peripheral and central, did not work and the 
blood in drainage sack coagulated very quickly. We per-
formed another surgery: the forearm flap appeared very 
congested, we tried once again to restore venous flow, but 
Fig. 1. Radial forearm free flap well perfused.
Fig. 2. Platelet profile during post-op days.
Fig. 3. Radial forearm free flap, after the second re-exploration.
Fig. 4. Venous stasis of the radial forearm free flap.
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every attempt was unsuccessful. We finally decided to re-
move the flap and to change the reconstructive technique: 
the wound was closed with a facial artery myo-mucosal 
(FAMM) flap. 
A haematologist was consulted and specific coagula-
tion tests were performed: on the morning of the 6th 
postoperative day we received the results: heparin-PF4 
antibodies resulted positive by enzyme-linked immuno-
assay (ELISA). The haematologist rendered a diagno-
sis of HITT. We promptly substituted low body weight 
heparin (LBWH) with fondaparinux, a synthetic hepa-
rin-like polysaccharide targeting only the coagulation 
factor Xa and without affinity for PF4, avoiding the for-
mation of heparin/PF4 antibody complexes. In the fol-
lowing days, the platelet count, which had dropped at 
least at 120x109 at the apex of the manifestations on the 
5th day, increased to 483-529 x 109, further supporting 
a diagnosis of HITT. The patient’s recovery continued 
without complications, and the fondaparinux dose was 
increased up to 7.5 mg/day. He was discharged on the 
21th day after the first surgery; 3 weeks later the auton-
omization of the pedicled flap was accomplished with-
out further complications. 
Discussion
HITT is a syndrome caused by the presence of antibod-
ies linked to complex platelet factor 4 (PF4), which are 
exposed after heparin linkage. Among all antibodies, IgG 
are those that provoke platelet activation and aggregation, 
leading to thrombocytopenia and, in 50% of cases, throm-
botic events. A diagnosis of thrombocytopenia is made 
when the platelets count is less than 150,000/mm3 or when 
the decrease is more than 50%; the thrombotic events usu-
ally involve veins, with a venous:arterious ratio of 4:1 13. 
HITT manifests in two different forms. Type 1 depends 
on the direct activation of platelet heparin-mediated and is 
asymptomatic: thrombocytopenia resolves spontaneously 
in 1-2 days, normally without thrombotic events, and no 
intervention is usually required 14. HITT type 2 is plate-
let activation mediated by immuno-complex  15: it man-
ifests later, usually in 4-10  days after heparin exposure 
and thrombotic events are co-existing, usually involving 
organs or tissues with pre-existing endothelial injury  16; 
there is also a so-called “local-form” characterised by 
flap loss occurring very early in the post-operative course, 
with no drop in platelet counts 8. The risk of developing 
HITT is correlated to the type of heparin: the major risk 
is with bovine heparin and with LBWH. The antibodies 
completely disappear in 100 days 17. Rapid diagnosis of 
HITT is challenging: it manifests in unexpected ways, it’s 
hard to recognise and unfortunately the consequences of 
diagnostic delay can be dramatic: flow impairment to the 
flap can result in flap loss, nullifying the efficacy of the 
surgery 18. Typically heparin prophylaxis is administered 
to prevent venous flow impairment; when venous suffer-
ing is recognised, leech therapy is usually introduced, and 
can gradually resolve the situation. If leeches do not work, 
surgical revision is required: during surgery it is possible 
to directly see anastomosis, remove thrombi and locally 
administer fibrinolytic drugs, such as t-PA. 
There is no general consensus about thrombosis preven-
tion  19, but heparin therapy still remains a cornerstone 
during postoperative microsurgery: the paradox is that the 
therapy is the cause of the thrombosis, and this explains 
the difficulty in diagnosing HITT. Laboratory tests typi-
cally show thrombocytopenia after clinical manifestations 
that could be referred to other causes; systemic manifesta-
tions of thrombosis do not manifest, sustaining the proba-
bility of a local problem. Furthermore, routine anamnesis 
does not investigate prior heparin therapy, and even if well 
investigated, prior assumption of heparin is not an essen-
tial diagnostic information because it could occur even in 
heparin naive patients 9. 
When the microsurgeon has to face venous drainage 
complications the first doubt is technical error 20. In rou-
tine surgical activity, local problems are more easily be-
lieved to be the cause of venous congestion, more than 
a misdiagnosed systemic condition. All these aspects 
clarify the problems in HITT diagnosis: the time gap 
between the first clinical sign and diagnosis is usually 
enough to lead to irrecoverable damage (Table I). Hy-
percoagulability state, hereditary or acquired, is quite 
frequent in the general population and unrecognised 
coagulopathies represent a significant cause of flap fail-
ure 21. We also have to consider the typology of patient 
undergoing reconstruction in head and neck surgery: 
the patient is usual oncological, as in our case, and fre-
quently is a heavy smoker: both these factors increase 
propensity to clot formation. Furthermore, microsur-
gery itself may concur to thrombosis: the handling of 
vessels, with micro-damage on the endothelium, and the 
long surgical time, with prolonged immobilisation, may 
play a role in thrombotic aetiology. Dramatic outcomes 
in free flap surgery due to unpredictable thrombotic 
events are reported in the literature: from the experience 
with unknown coagulopathic patients the importance 
of specific anamnesis can be recognised, investigating 
about thrombophilia, not only in the patient but also in 
the family 22; differently, the patient at risk for HITT 
cannot be recognised previously: the search for antibod-
ies cannot be routinely performed and is not useful be-
cause they disappear at about 100 days after the mani-
festations; perhaps the only useful anamnestic data is 
previous exposure to heparin but, as already mentioned, 
is not specific for HITT diagnosis. Diagnosis is assessed 
only with a laboratory test that should be requested as 
soon as possible in order to break the chain of events: a 
prompt suspicion of HITT may be helpful in reducing 
negative outcomes. Warkentin and Heddle suggested a 
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pre-lab test score (“4T score”) 23: clinical data and lab 
exam determine the grade of risk for HITT (Table II): 
evidence of a low score demonstrates unlikely HITT 
(< 5%), an intermediate score (4-5) has a clinical profile 
of HITT, but alternative explanations may still be rel-
evant, and finally a high score representing a likely case 
of HITT (> 80%). This clinical score has been evaluated 
by both prospective and retrospective studies and has 
been demonstrated to have a predictive negative value 
(PNV) of 100% 24. Whenever thrombotic complications 
occur HITT diagnosis should be considered, and this 
clinical test should be kept in mind as it allows address-
ing suspicions toward intrinsic alterations in coagula-
tion. 
Conclusions
In reconstructive microsurgery unexpected thrombosis is 
a very serious complication that, if untreated, can lead to 
flap necrosis. A prompt and correct diagnosis followed by 
appropriate therapy is mandatory. The microsurgeon usu-
ally suspects technical error or some other local problem; 
systemic alterations are considered as a possible cause of 
thrombosis secondarily, also because routine coagulation 
tests are considered sufficient to discriminate coagulopathic 
patients. Furthermore, the absence of a general consensus 
about post-operative anticoagulation therapy complicates 
the management of thrombotic manifestations. The case 
presented summarises very well as diagnosis of HITT is 
difficult: a healthy young patient, non-smoker, silent anam-
nesis, platelet count and PT and PTT in normal range and 
the onset of haemorrhagic problems: all these aspects con-
tribute to deviating one’s attention. The result was devastat-
ing: four re-exploration surgeries and two free flap failures. 
The 4T test could be a valid aid for HITT diagnosis because 
clinical evaluation alone is insufficient and laboratory con-
firmation requires cost and time. At present, the most useful 
and feasible tool for HITT suspicion is complete anamnesis 
investigating not only coagulopathic risk, as proposed by 
Friedman et al. 22, but also investigating prior heparin ex-
posure (Table III). 
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